BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 18189184)

  • 1. Prospective evaluation of ondansetron for undifferentiated nausea and vomiting in the prehospital setting.
    Warden CR; Moreno R; Daya M
    Prehosp Emerg Care; 2008; 12(1):87-91. PubMed ID: 18189184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ondansetron is safe and effective for prehospital treatment of nausea and vomiting by paramedics.
    Salvucci AA; Squire B; Burdick M; Luoto M; Brazzel D; Vaezazizi R
    Prehosp Emerg Care; 2011; 15(1):34-8. PubMed ID: 21091329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ondansetron oral dissolving tablets are superior to normal saline alone for prehospital nausea.
    Fullerton L; Weiss SJ; Froman P; Oglesbee S; Cheney P
    Prehosp Emerg Care; 2012; 16(4):463-8. PubMed ID: 22742574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of ondansetron for prevention of postoperative nausea and vomiting after outpatient ear surgery under local anesthesia.
    Ku PK; Tong MC; Lo P; van Hasselt CA
    Am J Otol; 2000 Jan; 21(1):24-7. PubMed ID: 10651430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haloperidol vs. ondansetron for the prevention of postoperative nausea and vomiting following gynaecological surgery.
    Aouad MT; Siddik-Sayyid SM; Taha SK; Azar MS; Nasr VG; Hakki MA; Zoorob DG; Baraka AS
    Eur J Anaesthesiol; 2007 Feb; 24(2):171-8. PubMed ID: 16938159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double-blind, noninferiority trial.
    Braude D; Crandall C
    Acad Emerg Med; 2008 Mar; 15(3):209-15. PubMed ID: 18304050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
    Yeo W; Mo FK; Suen JJ; Ho WM; Chan SL; Lau W; Koh J; Yeung WK; Kwan WH; Lee KK; Mok TS; Poon AN; Lam KC; Hui EK; Zee B
    Breast Cancer Res Treat; 2009 Feb; 113(3):529-35. PubMed ID: 18327706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide, and placebo.
    Egerton-Warburton D; Meek R; Mee MJ; Braitberg G
    Ann Emerg Med; 2014 Nov; 64(5):526-532.e1. PubMed ID: 24818542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting.
    Gan TJ; Sinha AC; Kovac AL; Jones RK; Cohen SA; Battikha JP; Deutsch JS; Pergolizzi JV; ; Glass PS
    Anesth Analg; 2009 May; 108(5):1498-504. PubMed ID: 19372328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blinded comparison of ondansetron, granisetron, and placebo for prevention of postoperative nausea and vomiting after supratentorial craniotomy.
    Jain V; Mitra JK; Rath GP; Prabhakar H; Bithal PK; Dash HH
    J Neurosurg Anesthesiol; 2009 Jul; 21(3):226-30. PubMed ID: 19543000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy and safety of combinations of metopimazine or ondansetron with methylprednisolone in the prevention of delayed emesis in patients receiving chemotherapy.
    Bloch J; Rixe O; Meric JB; Delgado A; Khayat D
    Curr Med Res Opin; 2005 Nov; 21(11):1763-71. PubMed ID: 16307696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of transdermal scopolamine on the incidence and severity of postoperative nausea and vomiting in a group of high-risk patients given prophylactic intravenous ondansetron.
    Jones S; Strobl R; Crosby D; Burkard JF; Maye J; Pellegrini JE
    AANA J; 2006 Apr; 74(2):127-32. PubMed ID: 16617916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-hydroxytryptamine-3 receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation induced emesis: a placebo-controlled randomized trial of the National Cancer Institute of Canada Clinical Trials Group (SC19).
    ; Wong RK; Paul N; Ding K; Whitehead M; Brundage M; Fyles A; Wilke D; Nabid A; Fortin A; Wilson D; McKenzie M; Ackerman I; Souhami L; Chabot P; Pater J
    J Clin Oncol; 2006 Jul; 24(21):3458-64. PubMed ID: 16849762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ondansetron vs. metoclopramide for the prevention of nausea and vomiting after gynecologic surgery.
    Krobbuaban B; Pitakpol S; Diregpoke S
    J Med Assoc Thai; 2008 May; 91(5):669-74. PubMed ID: 18672630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No more than necessary: safety and efficacy of low-dose promethazine.
    Moser JD; Caldwell JB; Rhule FJ
    Ann Pharmacother; 2006 Jan; 40(1):45-8. PubMed ID: 16352779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
    Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acupuncture to reduce nausea during chemotherapy treatment of rheumatic diseases.
    Josefson A; Kreuter M
    Rheumatology (Oxford); 2003 Oct; 42(10):1149-54. PubMed ID: 12777644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-controlled analgesia combined with either ondansetron or ondansetron plus prochlorperazine for control of pain and nausea and vomiting in patients undergoing abdominal surgery.
    Jellish WS; Owen K; Fluder E; Sawicki K; Sinacore J
    J Clin Anesth; 2008 Dec; 20(8):594-600. PubMed ID: 19100932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermediate dose metoclopramide is not more effective than standard dose metoclopramide for patients who present to the emergency department with nausea and vomiting: a pilot study.
    Cham S; Basire M; Kelly AM
    Emerg Med Australas; 2004 Jun; 16(3):208-11. PubMed ID: 15228463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?
    Hamadani M; Chaudhary L; Awan FT; Khan JK; Kojouri K; Ozer H; Tfayli A
    J Oncol Pharm Pract; 2007 Jun; 13(2):69-75. PubMed ID: 17873106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.